Hayward, California, United StatesFounded 200659+ employeesPrivate
$244.2M raisedGrowth· last: series d (Aug 2024)· 9 rounds
Backed by(14 investors)
New Enterprise Associates · LeadAdvent Life Sciences · LeadFuture Fund · LeadElevage Medical Technologies · LeadRunway Growth Capital · Lead+8 more
Moximed focuses on enhancing care for patients suffering from osteoarthritis, particularly through the MISHA Knee System. This system offers an outpatient treatment option for those who have not found relief from other therapies and are not candidates for knee replacement. The company aims to improve patients' quality of life by addressing their specific needs and challenges.
